New technology could create the world's first cure for heart attacks
Date
4/18/2022 6:17:21 AM
(MENAFN- Khaama Press)
Scientists have identified similar genetic codes to those used to create Covid vaccines, and are applying the information toward regenerating hearts damaged from cardiac arrests.
Scientists at King's College London are leading the groundbreaking research, which could eventually lead to the world's first heart attack cure, reports The Times.
The key genetic code, known as mRNA, produce proteins that stimulate the creation of healthy new cells.
The new approach has been dubbed revolutionary and has, so far, been successfully used to regenerate damaged pig hearts.
Human trials are expected to run within two years.
Professor Mauro Giacca explained:“We are all born with a set number of muscle cells in our heart and they are exactly the same ones we will die with.
“The heart has no capacity to repair itself after a heart attack. Our goal has been to find a treatment that can convince surviving cells to proliferate.
“Regenerating a damaged human heart has been a dream until a few years ago, but can now become a reality.
Giacca's team, based at the British Heart Foundation Centre for Research Excellence at King's, is also developing a treatment to prevent cells from dying during a heart attack.
“The treatment revolution that has occurred in cancer in recent years, where there is immunotherapy and targeted biological therapies, has not occurred for the heart.
“Treatment for heart attacks and heart failure remains very similar to 50 years ago and the main pillars of therapy are drugs that were developed in the 1970s such as beta-blockers and ACE inhibitors.”
MENAFN18042022000228011069ID1104039843
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.